Articles Referencing BDSI

Zacks.com

FDA Action Date for AMAG Drug - Analyst Blog

AMAG Pharmaceuticals, Inc. ( AMAG ) recently announced that its supplemental new drug application (sNDA) for Feraheme (ferumoxytol) has been accepted by the US Food and Drug Administration... Read >>

Zacks.com

Infinity Reports Wider Loss - Analyst Blog

Infinity Pharmaceuticals Inc. ( INFI ) reported a loss of $1.15 per share in the fourth quarter of 2012, wider than the year-ago loss of 53 cents and the Zacks Consensus Estimate of a loss... Read >>

Zacks.com

AMAG Narrows Loss, Maintains View - Analyst Blog

AMAG Pharmaceuticals Inc. 's ( AMAG ) fourth quarter 2012 loss of 14 cents per share was narrower than the year-ago loss of 71 cents but wider than the Zacks Consensus Estimate of a loss of... Read >>

Zacks.com

4Q Beat for The Medicines Co. - Analyst Blog

The Medicines Company ( MDCO ) reported fourth quarter earnings of 71 cents per share, compared with the year-ago earnings of 48 cents per share. The Zacks Consensus Estimate for the fourth... Read >>

Zacks.com

Encouraging News at Chelsea - Analyst Blog

Chelsea Therapeutics International Ltd. ( CHTP ) recently announced that it received written guidance from the Director of the Office of New Drugs at the US Food and Drug... Read >>

GuruFocus

Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX

According to GuruFocus Insider Data , the largest CFO sells during the past week were: BioDelivery Sciences International Inc., Linkedin Corporation, Verisk Analytics Inc., ABIOMED Inc. and... Read >>

SeekingAlpha

Four Biotech Stocks to Play the Sector Pullback

VFC submits: When an entire sector - or the broad market as a whole - decides to take a dip, that's when I like to go on a buying spree and as investors of the biotech/small pharma sector... Read >>